Physician profile
Kipp Slicker
NPI 1891922498
$6,948.81
in general payments reported to CMS, 2019-2025
26 companies · $625 in 2025
The $625 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $2,062 · 2021: $734 · 2022: $867 · 2023: $906 · 2024: $1,327 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,858.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,529.86 | 2020-2024 | |
| Janssen Pharmaceuticals, INC | $1,272.47 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $1,096.11 | 2020-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $600.91 | 2021-2024 | Symplicity G3, Onyx Frontier, Telescope |
| Novartis Pharmaceuticals Corporation | $561.73 | 2019-2025 | |
| Abbott Laboratories | $288.96 | 2019-2024 | Aveir, Perclose Prostyle, Diamondback Coronary |
| Boston Scientific Corporation | $256.74 | 2022-2024 | Synergy, Avvigo Guidance System, Watchman Flx |
| Shockwave Medical, INC | $253.13 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abiomed | $177.09 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $131.37 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $117.77 | 2023-2025 | Camzyos, Eliquis |
| Cvrx, INC. | $95.46 | 2025 | Barostim Neo System |
| Cardiovascular Systems INC. | $94.73 | 2020-2022 | |
| Livanova USA, INC. | $77.57 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.41 | 2020-2024 | Lifevest |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $70.03 | 2023-2024 | Inpefa |
| Cardiva Medical, INC. | $64.90 | 2023-2024 | Savvywire, Optowire, Cardiva Vascade 6/7f Vcs |
| Esperion Therapeutics, INC. | $64.25 | 2021-2024 | Nexletol |
| Chiesi USA, INC. | $19.98 | 2024 | Cleviprex, Kengreal |
| Amgen INC. | $17.60 | 2025 | Repatha |
| Alnylam Pharmaceuticals INC. | $17.23 | 2019 | |
| Biotronik INC. | $16.52 | 2020 | |
| Inspire Medical Systems, INC. | $15.12 | 2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $13.80 | 2020 | |
| Merck Sharp & Dohme LLC | $12.07 | 2022 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kipp Slicker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.